Gail R. Wilensky's most recent trade in Quest Diagnostics, Inc. was a trade of 1,369 Common Stock done . Disclosure was reported to the exchange on May 17, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Quest Diagnostics | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 1,369 | 20,506 (0%) | 0% | 0 | Common Stock | |
Quest Diagnostics | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 1,292 | 19,137 (0%) | 0% | 0 | Common Stock | |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 100 | 24,690 (0%) | 0% | 0 | Common Stock | |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 68 | 24,590 (0%) | 0% | 0 | Common Stock | |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 103 | 24,522 (0%) | 0% | 0 | Common Stock | |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 72 | 24,419 (0%) | 0% | 0 | Common Stock | |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 131 | 24,347 (0%) | 0% | 0 | Common Stock | |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2021 | 82 | 24,216 (0%) | 0% | 0 | Common Stock | |
Quest Diagnostics | Gail R. Wilensky | Director | Sale of securities on an exchange or to another person at price $ 139.32 per share. | 27 Jul 2021 | 6,111 | 17,845 (0%) | 0% | 139.3 | 851,403 | Common Stock |
Quest Diagnostics | Gail R. Wilensky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2021 | 6,111 | 0 | - | - | Stock Options (Right to Buy) | |
Quest Diagnostics | Gail R. Wilensky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2021 | 6,111 | 0 | - | - | Stock Options (Right to Buy) | |
Quest Diagnostics | Gail R. Wilensky | Director | Sale of securities on an exchange or to another person at price $ 139.27 per share. | 27 Jul 2021 | 6,111 | 17,845 (0%) | 0% | 139.3 | 851,067 | Common Stock |
Quest Diagnostics | Gail R. Wilensky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.23 per share. | 27 Jul 2021 | 6,111 | 23,956 (0%) | 0% | 61.2 | 374,146 | Common Stock |
Quest Diagnostics | Gail R. Wilensky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.57 per share. | 27 Jul 2021 | 6,111 | 23,956 (0%) | 0% | 57.6 | 351,780 | Common Stock |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 121 | 24,134 (0%) | 0% | 0 | Common Stock | |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 7 | 24,013 (0%) | 0% | 0 | Common Stock | |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 85 | 24,006 (0%) | 0% | 0 | Common Stock | |
Quest Diagnostics | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 1,363 | 17,845 (0%) | 0% | 0 | Common Stock | |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 140 | 23,921 (0%) | 0% | 0 | Common Stock | |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2021 | 79 | 23,781 (0%) | 0% | 0 | Common Stock | |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 147 | 23,702 (0%) | 0% | 0 | Common Stock | |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 85 | 23,555 (0%) | 0% | 0 | Common Stock | |
Quest Diagnostics | Gail R. Wilensky | Director | Sale of securities on an exchange or to another person at price $ 126.02 per share. | 24 Nov 2020 | 6,111 | 16,482 (0%) | 0% | 126.0 | 770,120 | Common Stock |
Quest Diagnostics | Gail R. Wilensky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2020 | 6,111 | 0 | - | - | Stock Options (Right to Buy) | |
Quest Diagnostics | Gail R. Wilensky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.67 per share. | 24 Nov 2020 | 6,111 | 22,593 (0%) | 0% | 57.7 | 352,391 | Common Stock |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 164 | 23,470 (0%) | 0% | 0 | Common Stock | |
UnitedHealth | Gail R. Wilensky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2020 | 97 | 23,306 (0%) | 0% | 0 | Common Stock |